1-hydroxybenzo[b]phenazine 5,12-dioxide

ID: ALA4777695

Chembl Id: CHEMBL4777695

PubChem CID: 137284998

Max Phase: Preclinical

Molecular Formula: C16H10N2O3

Molecular Weight: 278.27

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  [O-][n+]1c2cc3ccccc3cc2[n+]([O-])c2c(O)cccc21

Standard InChI:  InChI=1S/C16H10N2O3/c19-15-7-3-6-12-16(15)18(21)14-9-11-5-2-1-4-10(11)8-13(14)17(12)20/h1-9,19H

Standard InChI Key:  YGRBOGDNUCZASW-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA4777695

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 278.27

Molecular Weight (Monoisotopic): 278.0691

AlogP: 2.12

#Rotatable Bonds: 0

Polar Surface Area: 74.11

Molecular Species: ACID

HBA: 3

HBD: 1

#RO5 Violations: 0

HBA (Lipinski): 5

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 5.37

CX Basic pKa: 2.48

CX LogP: 1.87

CX LogD: 0.20

Aromatic Rings: 4

Heavy Atoms: 21

QED Weighted: 0.30

Np Likeness Score: 0.19

References

1. Viktorsson, Elvar Orn, Aesoy, Reidun, Stoa, Sindre, Lekve, Viola, Doskeland, Stein Ove, Herfindal, Lars, Rongved, Pal.  (2021)  New prodrugs and analogs of the phenazine 5,10-dioxide natural products iodinin and myxin promote selective cytotoxicity towards human acute myeloid leukemia cells,  12  (5.0): [PMID:34124675] [10.1039/d1md00020a]

Source

Source(1):

• Scientific Literature